UC-San Francisco Researchers Receive $13.2M Grant To Study Genetic Response to Statins
A team of researchers at UC-San Francisco has been awarded a five-year, $13.2 million federal grant to examine the genetics behind statin response. Recent studies have questioned the potential side effects of statins, which are a commonly prescribed class of drugs used to lower cholesterol. The study aligns with UCSF's focus on precision medicine initiatives to study the genetics associated with disease diagnosis and drug response.
- "Do Statins Work? UCSF Studying the Pharmacogenomics of These Widely Prescribed Drugs" (Keshavan, MedCity News, 9/9).